Pricing Log in Create free account

Ernexa Therapeutics Inc. (ERNA) vs 60 Degrees Pharmaceuticals Inc. (SXTP)

Ernexa Therapeutics Inc. and 60 Degrees Pharmaceuticals Inc. are both Biotechnology companies. Ernexa Therapeutics Inc. and 60 Degrees Pharmaceuticals Inc. are of similar size ($3.2M and $3.0M). 60 Degrees Pharmaceuticals Inc. grew revenue faster over the last twelve months: 23.4% against −78.6%. Ernexa Therapeutics Inc. has the higher net margin (0.00% vs −678.0%) and the higher return on invested capital (0.00% vs −348.6%). Across the 16 metrics below, Ernexa Therapeutics Inc. leads on 10 and 60 Degrees Pharmaceuticals Inc. on 6.

Valuation

Metric ERNA SXTP Biotechnology median
P/E n/m n/m 10.60
P/S 3.82 1.31 9.40
P/B 0.70 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 50.76 1.47 9.02
Earnings yield (992.55%) (1,046.67%) (32.88%)
Free cash flow yield (399.18%) (569.15%) (23.13%)

Profitability

Metric ERNA SXTP Biotechnology median
Gross margin 83.51% 43.42% 68.51%
Operating margin 0.00% (691.33%) 0.00%
Net margin 0.00% (678.03%) 0.00%
Free cash flow margin 0.00% (745.93%) 0.00%
Return on equity (321.22%) 115.54% (51.96%)
Return on assets (176.62%) (194.65%) (46.06%)
Return on invested capital 0.00% (348.64%) 0.00%

Growth

Metric ERNA SXTP Biotechnology median
Revenue growth (TTM) (78.60%) 23.41% 6.76%
EPS growth (last fiscal year) 95.42% 84.19% 29.88%
Revenue growth, 5-year CAGR (52.20%) (11.18%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ERNA SXTP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.01 2.32 4.97
Net debt to EBITDA 0.21 0.37 1.01

Dividend

Metric ERNA SXTP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ERNA SXTP Biotechnology median
Market cap 2.99m 3.22m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack